Identification of genetic heterogeneity of Alzheimer's disease across age (original) (raw)

2019, Neurobiology of Aging

The risk of APOE for Alzheimer's Disease (AD) is modified by age. Beyond APOE, the polygenic architecture may also be heterogeneous across age. We aim to investigate age-related genetic heterogeneity of AD and identify genomic loci with differential effects across age. Stratified genebased genome-wide association studies (GWAS) and polygenic variation analyses were performed in the younger (60-79 years, N = 14,895) and older (≥ 80 years, N = 6,559) age-at-onset groups using Alzheimer's Disease Genetics Consortium data. We showed a moderate genetic correlation (r g = 0.64) between the two age groups, supporting genetic heterogeneity. Heritability explained by variants on chromosome 19 (harboring APOE) was significantly larger in younger than in older onset group (P < 0.05). APOE region, BIN1, OR2S2, MS4A4E and PICALM were identified at the gene-based genome-wide significance (P < 2.73×10 −6) with larger effects at younger age (except MS4A4E). For the novel gene OR2S2, we further performed leave-one-out analyses, which showed consistent effects across subsamples. Our results suggest using genetically more homogeneous individuals may help detect additional susceptible loci.

Sign up for access to the world's latest research.

checkGet notified about relevant papers

checkSave papers to use in your research

checkJoin the discussion with peers

checkTrack your impact